Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Net Income (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Net Income for 16 consecutive years, with -$4.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income rose 75.84% year-over-year to -$4.5 million, compared with a TTM value of -$94.4 million through Dec 2025, up 18.11%, and an annual FY2025 reading of -$94.4 million, up 18.11% over the prior year.
  • Net Income was -$4.5 million for Q4 2025 at Orthofix Medical, up from -$22.8 million in the prior quarter.
  • Across five years, Net Income topped out at $16.1 million in Q4 2022 and bottomed at -$60.9 million in Q1 2023.
  • Average Net Income over 5 years is -$19.4 million, with a median of -$20.3 million recorded in 2023.
  • The sharpest move saw Net Income soared 163.55% in 2022, then crashed 1684.01% in 2023.
  • Year by year, Net Income stood at -$25.3 million in 2021, then skyrocketed by 163.55% to $16.1 million in 2022, then plummeted by 237.89% to -$22.2 million in 2023, then grew by 16.71% to -$18.5 million in 2024, then surged by 75.84% to -$4.5 million in 2025.
  • Business Quant data shows Net Income for OFIX at -$4.5 million in Q4 2025, -$22.8 million in Q3 2025, and -$14.1 million in Q2 2025.